nach oben

Breast Cancer Research

Erschienen in:

01.08.2012 | Meeting report

New methods in mammary gland development and cancer: proteomics, epigenetics, symmetric division and metastasis

verfasst von: Mohamed Bentires-Alj, Marina Glukhova, Nancy Hynes, Maria dM Vivanco

Erschienen in: Breast Cancer Research | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The European Network for Breast Development and Cancer (ENBDC) meeting on 'Methods in Mammary Gland Development and Cancer' has become an annual international rendezvous for scientists with interests in the normal and neoplastic breast. The fourth meeting in this series, held in April in Weggis, Switzerland, focused on proteomics, epigenetics, symmetric division, and metastasis.

Fienberg HG, Simonds EF, Fantl WJ, Nolan GP, Bodenmiller B: A platinum-based covalent viability reagent for single-cell mass cytometry. Cytometry A. 2012, 81: 467-475.CrossRefPubMed

Bendall SC, Nolan GP, Roederer M, Chattopadhyay PK: A deep profiler's guide to cytometry. Trends Immunol. 2012, 33: 323-332.CrossRefPubMedPubMedCentral

Braakman RB, Luider TM, Martens JW, Foekens JA, Umar A: Laser capture microdissection applications in breast cancer proteomics. Methods Mol Biol. 2011, 755: 143-154. 10.1007/978-1-61779-163-5_11.CrossRefPubMed

Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038/35021093.CrossRefPubMed

Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS: FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet. 2011, 43: 27-33. 10.1038/ng.730.CrossRefPubMed

Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC Group, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C, Aparicio S: The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012, 486: 346-352.PubMedPubMedCentral

Clayton E, Doupe DP, Klein AM, Winton DJ, Simons BD, Jones PH: A single type of progenitor cell maintains normal epidermis. Nature. 2007, 446: 185-189. 10.1038/nature05574.CrossRefPubMed

Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, Barker N, Klein AM, van Rheenen J, Simons BD, Clevers H: Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell. 2010, 143: 134-144. 10.1016/j.cell.2010.09.016.CrossRefPubMed

Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG, Di Fiore PP: Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 2010, 140: 62-73. 10.1016/j.cell.2009.12.007.CrossRefPubMed

10.

Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, Pelicci PG: The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell. 2009, 138: 1083-1095. 10.1016/j.cell.2009.06.048.CrossRefPubMed

11.

Nola S, Sin S, Bonin F, Lidereau R, Driouch K: A methodological approach to unravel organ-specific breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2012, [Epub ahead of print]

12.

Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bièche I, Bellahcène A, Castronovo V, de Wever O, Gespach C, Lidereau R, Driouch K: Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis. J Natl Cancer Inst. 2011, 103: 1323-1337. 10.1093/jnci/djr290.CrossRefPubMed

13.

Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975, 55: 231-273.PubMed

14.

Behbod F, Kittrell FS, LaMarca H, Edwards D, Kerbawy S, Heestand JC, Young E, Mukhopadhyay P, Yeh HW, Allred DC, Hu M, Polyak K, Rosen JM, Medina D: An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 2009, 11: R66-10.1186/bcr2358.CrossRefPubMedPubMedCentral

15.

Valdez KE, Fan F, Smith W, Allred DC, Medina D, Behbod F: Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model. J Pathol. 2011, 225: 565-573. 10.1002/path.2969.CrossRefPubMedPubMedCentral

Titel: New methods in mammary gland development and cancer: proteomics, epigenetics, symmetric division and metastasis
verfasst von: Mohamed Bentires-Alj
Marina Glukhova
Nancy Hynes
Maria dM Vivanco
Publikationsdatum: 01.08.2012
Verlag: BioMed Central
Erschienen in: Breast Cancer Research / Ausgabe 4/2012
Elektronische ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr3216

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

New methods in mammary gland development and cancer: proteomics, epigenetics, symmetric division and metastasis

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Mammographic density as a mediator for breast cancer risk: analytic approaches

FGFR1 is amplified during the progression of in situto invasive breast carcinoma

A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy

The interaction between ER and NFκB in resistance to endocrine therapy

Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells

Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie